Tezepelumab Reverses TSLP ‐Driven Immunometabolic Rewiring in Human cDC2s Underlying Pathogenic Th2 and Dysfunctional Treg Responses

Allergy: European Journal of Allergy and Clinical Immunology · Published 2026-07-31 · DOI 10.1111/all.70470

Authors (6)

Leticia Martín‐Cruz, Andrés de la Rocha‐Muñoz, Isabel María Peñalver‐Fernández, Ángel Maldonado, Sofía Sirvent, Oscar Palomares

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Martín‐Cruz, L., Rocha‐Muñoz, A., Peñalver‐Fernández, I., et al. (2026). Tezepelumab Reverses TSLP ‐Driven Immunometabolic Rewiring in Human cDC2s Underlying Pathogenic Th2 and Dysfunctional Treg Responses. Allergy: European Journal of Allergy and Clinical Immunology. https://doi.org/10.1111/all.70470

Related articles